Hepatitis B virus screening and reactivation and management of patients with nasopharyngeal carcinoma: A large‐scale, big‐data intelligence platform–based analysis from an endemic area
Jia‐Wei Lv(Sun Yat-sen University), Ying Sun(Key Laboratory of Guangdong Province), Ling‐Long Tang(Sun Yat-sen University), Yan‐Ping Mao(Sun Yat-sen University), Lei Chen(Zhuzhou Central Hospital), Jun Ma(Shanghai Institute of Technology), Rui‐Hua Xu(Sun Yat-sen University), Xiaodan Huang(Guangzhou University of Chinese Medicine), Wen‐Fei Li(Sun Yat-sen University), Yu‐Pei Chen(Sun Yat-sen University), Ying Guo(Sun Yat-sen University), Guan‐Qun Zhou(Sun Yat-sen University)
Cited by 71
Related Papers
Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study
|The Lancet Oncology|2011|4.1k
Circular RNA: metabolism, functions and interactions with proteins
|Molecular Cancer|2020|1.6k
Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma
|New England Journal of Medicine|2019|934
METTL3 facilitates tumor progression via an m6A-IGF2BP2-dependent mechanism in colorectal carcinoma
|Molecular Cancer|2019|868